Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation

AP Gureev, VN Popov, AA Starkov - Experimental neurology, 2020 - Elsevier
In recent years, a significant progress was made in understanding molecular mechanisms of
long-term memory. Long-term memory formation requires strengthening of neuronal …

Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease

T Ma, CA Hoeffer, E Capetillo-Zarate, F Yu, H Wong… - PloS one, 2010 - journals.plos.org
Background The mammalian target of rapamycin (mTOR) is an evolutionarily conserved
Ser/Thr protein kinase that plays a pivotal role in multiple fundamental biological processes …

The Interaction of mTOR and Nrf2 in Neurogenesis and Its Implication in Neurodegenerative Diseases

LI Zoungrana, M Krause-Hauch, H Wang, MK Fatmi… - Cells, 2022 - mdpi.com
Neurogenesis occurs in the brain during embryonic development and throughout adulthood.
Neurogenesis occurs in the hippocampus and under normal conditions and persists in two …

mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis

D Rapaka, VR Bitra, SR Challa, PC Adiukwu - Neurochemistry international, 2022 - Elsevier
Mechanistic/mammalian target of rapamycin (mTOR) belongs to the phosphatidylinositol
kinase-related kinase (PIKK) family. mTOR signaling is required for the commencement of …

Targeting the mTOR signaling network for Alzheimer's disease therapy

C Wang, JT Yu, D Miao, ZC Wu, MS Tan, L Tan - Molecular neurobiology, 2014 - Springer
The mammalian target of rapamycin (mTOR) is a highly conserved serine/threonine kinase
that can sense environmental stimuli such as growth factors, energy state, and nutrients. It is …

mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder

M Perluigi, F Di Domenico, E Barone… - Free Radical Biology and …, 2021 - Elsevier
Alzheimer's disease (AD) is the most prevalent form of dementia in the elderly population
and has worldwide impact. The etiology of the disease is complex and results from the …

mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy

M Perluigi, F Di Domenico, DA Butterfield - Neurobiology of disease, 2015 - Elsevier
Compelling evidence indicates that the mammalian target of rapamycin (mTOR) signaling
pathway is involved in cellular senescence, organismal aging and age-dependent diseases …

Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies

A Tramutola, C Lanzillotta… - Expert Review of …, 2017 - Taylor & Francis
Introduction: The mTOR pathway is involved in the regulation of a wide repertoire of cellular
functions in the brain and its dysregulation is emerging as a leitmotif in a large number of …

Activation of mTOR: a culprit of Alzheimer's disease?

Z Cai, G Chen, W He, M Xiao, LJ Yan - … disease and treatment, 2015 - Taylor & Francis
Alzheimer's disease (AD) is characterized by cognitive impairment in clinical presentation,
and by β-amyloid (Aβ) production and the hyper-phosphorylation of tau in basic research …

mTOR‐dependent signalling in Alzheimer's disease

JJ Pei, J Hugon - Journal of cellular and molecular medicine, 2008 - Wiley Online Library
• Introduction• Neurodegeneration and neurofibrillary degeneration in Alzheimer's disease
brains• Dysfunction of protein synthesis mediated by mTOR‐dependent signalling in …